BACKGROUND: Dyslipidemia is a common disorder that causes atherosclerotic changes in the arteries leading to several Cardiovasular diseases. For treating Dyslipidemia, several treatment options are available nowadays. This study was done to evaluate the importance of Antimiasmatic treatment in treatment of Dyslipidemia. METHODS: A clinical study on 30 cases with Dyslipidemia was done at Sarada Krishna Homoeopathic Medical College Hospital and Rural Centers. The study cases were selected as per the inclusion criteria and diagnosis was mainly based on investigatory Lipid Profile Test. Improvement criteria were based on the Lipid Profile Test values and Body Mass Index levels. RESULTS: The study shows that Total Cholesterol values ar...
The present study is a comparative evaluation of the efficacy and side effect profile of Simvastati...
Introduction: Dyslipidemia mainly refers to a disbalance of any form of lipid in the body. Any disba...
<p><strong>Objective:</strong> To show the efficiency of dyslipidemia control in patients with coron...
Ischemic heart disease is the leading cause of death worldwide. A disruption to the perfusion and al...
Introduction:Hyperlipidaemia is an abnormally elevated levels of any or all lipids in the blood. A s...
Background: More than three quarters of cases of atherosclerosis are directly caused by abnormalitie...
Dyslipidaemia is a well-known risk factor for the development of cardiovascular disease, a leading c...
Importance of the field: Lipid-modifying drugs are therapeutic options that have been shown to reduc...
<p>Statins are used to reduce morbidity and mortality in patients with a high risk of cardiovascular...
Background: Metabolic syndrome (MetS) is a constellation of cardiometabolic risk determinants compri...
Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins h...
Objective: Describe the treatment of the patient with atherogenic dyslipidaemia (AD) in routine Prim...
Despite the availability of specific guidelines, the management of dyslipidemia in practice is not o...
Introduction and objectives: Cardiovascular disease and its associated comorbidities, including diab...
learnt from recent clinical trials? Cardiovascular disease is the leading cause of morbidity and mor...
The present study is a comparative evaluation of the efficacy and side effect profile of Simvastati...
Introduction: Dyslipidemia mainly refers to a disbalance of any form of lipid in the body. Any disba...
<p><strong>Objective:</strong> To show the efficiency of dyslipidemia control in patients with coron...
Ischemic heart disease is the leading cause of death worldwide. A disruption to the perfusion and al...
Introduction:Hyperlipidaemia is an abnormally elevated levels of any or all lipids in the blood. A s...
Background: More than three quarters of cases of atherosclerosis are directly caused by abnormalitie...
Dyslipidaemia is a well-known risk factor for the development of cardiovascular disease, a leading c...
Importance of the field: Lipid-modifying drugs are therapeutic options that have been shown to reduc...
<p>Statins are used to reduce morbidity and mortality in patients with a high risk of cardiovascular...
Background: Metabolic syndrome (MetS) is a constellation of cardiometabolic risk determinants compri...
Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins h...
Objective: Describe the treatment of the patient with atherogenic dyslipidaemia (AD) in routine Prim...
Despite the availability of specific guidelines, the management of dyslipidemia in practice is not o...
Introduction and objectives: Cardiovascular disease and its associated comorbidities, including diab...
learnt from recent clinical trials? Cardiovascular disease is the leading cause of morbidity and mor...
The present study is a comparative evaluation of the efficacy and side effect profile of Simvastati...
Introduction: Dyslipidemia mainly refers to a disbalance of any form of lipid in the body. Any disba...
<p><strong>Objective:</strong> To show the efficiency of dyslipidemia control in patients with coron...